<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2020</volume><submitter>Atalar E</submitter><funding>Abbott Inc</funding><pubmed_abstract>Maintaining regular blood pressure control usually requires multidrug regimens rather than monotherapy. The objective of this study was to describe the effectiveness and safety of an angiotensin-converting enzyme inhibitor and a nondihydropyridine calcium channel blocker in a single-tablet combination in patients with hypertension, a heart rate higher than 70 beats/min, and type 2 diabetes mellitus (T2DM). This study was conducted in Turkey as a prospective, noninterventional, observational study. At 22 clinical sites, the data of 200 patients with hypertension were used for efficacy analysis; however, 262 patients received at least one dose of trandolapril/verapamil fixed-dose combination at two dose strengths. Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, PR </pubmed_abstract><journal>BioMed research international</journal><pagination>2123601</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7492926</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.</pubmed_title><pmcid>PMC7492926</pmcid><pubmed_authors>Atalar E</pubmed_authors><pubmed_authors>Tugtekin HB</pubmed_authors><pubmed_authors>Kanyilmaz S</pubmed_authors><pubmed_authors>Karabulut A</pubmed_authors><pubmed_authors>Eskin F</pubmed_authors><pubmed_authors>Kirbiyik H</pubmed_authors><pubmed_authors>Ozyildiz AG</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.</name><description>Maintaining regular blood pressure control usually requires multidrug regimens rather than monotherapy. The objective of this study was to describe the effectiveness and safety of an angiotensin-converting enzyme inhibitor and a nondihydropyridine calcium channel blocker in a single-tablet combination in patients with hypertension, a heart rate higher than 70 beats/min, and type 2 diabetes mellitus (T2DM). This study was conducted in Turkey as a prospective, noninterventional, observational study. At 22 clinical sites, the data of 200 patients with hypertension were used for efficacy analysis; however, 262 patients received at least one dose of trandolapril/verapamil fixed-dose combination at two dose strengths. Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, PR </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-05T07:22:35.748Z</modification><creation>2020-10-01T07:06:15Z</creation></dates><accession>S-EPMC7492926</accession><cross_references><pubmed>32964020</pubmed><doi>10.1155/2020/2123601</doi></cross_references></HashMap>